Key statistics
On Friday, OptimizeRx Corp (OPRX:NAQ) closed at 4.87, 28.84% above the 52 week low of 3.78 set on Nov 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.53 |
---|---|
High | 5.02 |
Low | 4.47 |
Bid | 4.55 |
Offer | 4.86 |
Previous close | 4.49 |
Average volume | 587.72k |
---|---|
Shares outstanding | 18.42m |
Free float | 15.99m |
P/E (TTM) | -- |
Market cap | 82.71m USD |
EPS (TTM) | -1.33 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- OptimizeRx to Participate in Upcoming Investor Conferences
- OptimizeRx Reports Third Quarter 2024 Financial Results
- OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
- OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
- OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
- OptimizeRx Reports Second Quarter 2024 Financial Results
- OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
- OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
- OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
- New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
More ▼